Geode Capital Management, LLC Tff Pharmaceuticals, Inc. Transaction History

Geode Capital Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.31 - $0.48 $20,386 - $31,565	65,762 Added 35.0%	253,640 $88,000
Q4 2022 Feb 13, 2023	SELL	$0.84 - $100.75 $383 - $45,942	-456 Reduced 0.24%	187,878 $197,000
Q3 2022 Nov 14, 2022	BUY	$4.61 - $116.0 $13,885 - $349,392	3,012 Added 1.63%	188,334 $764,000
Q1 2022 May 13, 2022	BUY	$5.28 - $9.17 $49,383 - $85,767	9,353 Added 5.32%	185,322 $1.17 Million
Q4 2021 Feb 11, 2022	BUY	$6.86 - $9.65 $351,698 - $494,736	51,268 Added 41.11%	175,969 $1.56 Million
Q3 2021 Nov 12, 2021	BUY	$7.21 - $10.49 $17,296 - $25,165	2,399 Added 1.96%	124,701 $962,000
Q2 2021 Aug 13, 2021	BUY	$8.48 - $13.61 $130,524 - $209,485	15,392 Added 14.4%	122,302 $1.18 Million
Q1 2021 May 12, 2021	BUY	$12.96 - $19.75 $146,772 - $223,668	11,325 Added 11.85%	106,910 $1.45 Million
Q4 2020 Feb 12, 2021	BUY	$12.74 - $18.49 $233,103 - $338,311	18,297 Added 23.67%	95,585 $1.37 Million
Q3 2020 Nov 13, 2020	BUY	$5.86 - $18.47 $452,907 - $1.43 Million	77,288 New	77,288 $1.43 Million

Ticker TFFP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,477,800
Market Cap $1.53M
Description
TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and condit...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.